patellofemoral pain syndrome. Patellofemoral disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 18 and 45 years old. Self-reported anterior knee pain (unilateral or bilateral) when performing at least two of the following activities: prolonged sitting, squatting, kneeling, running, ascending and descending stairs, jumping and landing. Self-reported anterior knee pain with insidious onset lasting at least 3 months. Self- reported pain in the previous month should be at least 30 mm on a VAS scale of 100 mm.
Exclusion criteria
Exclusion criteria: Report of anterior knee pain caused by knee injury. History report of patellar dislocation. History of surgery in any lower limb joint. Report any history of meniscus damage, ligament instability or patellar tendinopathy . History of osteoarthritis in any lower limb joint. Rheumatic or neurological disease reported by the patient. Physiotherapy treatment for patellofemoral pain during the previous 6 months. History of current or past psychosis, major depressive episode, attempted suicide, post-traumatic stress disorder, bipolar disorder, manic episode, or substance dependence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS). Timepoint: They will be measured at the beginning of the study (before the intervention), immediately after the end of the treatment sessions (4 weeks) and two months after the end of the sessions. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Pain Catastrophizing Scale (PCS). Timepoint: They will be measured at the beginning of the study (before the intervention), immediately after the end of the treatment sessions (4 weeks) and two months after the end of the sessions. Method of measurement: 13-item questionnaire of fear of pain (Pain Catastrophizing Scale).;The Tampa scale for kinesiophobia (TSK). Timepoint: They will be measured at the beginning of the study (before the intervention), immediately after the end of the treatment sessions (4 weeks) and two months after the end of the sessions. Method of measurement: 17-item questionnaire of fear of movement (The Tampa scale for kinesiophobia).;The result of measurement of knee functional limitation by the patient. Timepoint: They will be measured at the beginning of the study (before the intervention), immediately after the end of the treatment sessions (4 weeks) and two months after the end of the sessions. Method of measurement: 13-item questionnaire of Kujala Patellofemoral Scale.;Outcome of treatment effectiveness. Timepoint: They will be measured immediately after the end of the treatment sessions (4 weeks) and two months after the end of the sessions. Method of measurement: The 7-point Likert global rating of change scale (GROC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences